The role of aspirin in childhood tuberculous meningitis

Journal of Child Neurology

Volumn 26, Issue 8, 2011, Pages 956-962

  Schoeman, Johan F ^a   Janse Van Rensburg, Anita ^a   Laubscher, Jacoba A ^b   Springer, Priscilla ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

aspirin; tuberculous meningitis

Indexed keywords

ACETYLSALICYLIC ACID; ETHIONAMIDE; ISONIAZID; PLACEBO; PYRAZINAMIDE; RIFAMPICIN;

ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CHILD; CHILD DEVELOPMENT; CHILDHOOD DISEASE; COGNITION; CONTROLLED STUDY; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; HEMATEMESIS; HEMIPARESIS; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEUROLOGIC EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TUBERCULOUS MENINGITIS;

ANTI-INFLAMMATORY AGENTS; ASPIRIN; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; PARESIS; STROKE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUBERCULOSIS, MENINGEAL;

EID: 79960672700     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073811398132     Document Type: Article

References (25)

1. van Well GT, Paes BF, Terwee CB, et al. Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the Western Cape of South Africa. Pediatrics. 2009 ; 123: e1 - e8
2. Padayatchi N, Bamber S, Dawood H, Bobat R. Multidrug-resistant tuberculous meningitis in children in Durban, South Africa. Pediatr Infect Dis J. 2006 ; 25: 147-150 (Pubitemid 43208569)
3. Donald PR, Schoeman JF. Tuberculous meningitis. N Engl J Med. 2004 ; 351: 1719-1720 (Pubitemid 39383206)
4. Lammie GA, Hewlett RH, Schoeman JF, Donald PR. Tuberculous cerebrovascular disease: a review. J Infect. 2009 ; 59: 156-166
5. Dastur DK, Lalitha VS, Udani PM, Parekh U. The brain and meninges in tuberculous meningitis-gross pathology in 100 cases and pathogenesis. Neurol India. 1970 ; 18: 86-100
6. Pienaar M, Andronikou S, van Toorn R. MRI to demonstrate diagnostic features and complications of TBM not seen with CT. Childs Nerv Syst. 2009 ; 25: 941-947
7. Thwaites GE, Schoeman JF. Update on tuberculosis of the central nervous system: pathogenesis, diagnosis, and treatment. Clin Chest Med. 2009 ; 30: 745-754
8. Springer P, Swanevelder S, van Toorn R, et al. Cerebral infarction and neurodevelopmental outcome in childhood tuberculous meningitis. Eur J Paediatr Neurol. 2009 ; 13: 343-349
9. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR. Serial CT scanning in childhood tuberculous meningitis: prognostic features in 198 cases. J Child Neurol. 1995 ; 10: 320-329
10. van der Merwe DJ, Andronikou S, Van Toorn R, Pienaar M. Brainstem ischemic lesions on MRI in children with tuberculous meningitis: with diffusion weighted confirmation. Childs Nerv Syst. 2009 ; 25: 949-954
11. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics. 1997 ; 99: 226-231 (Pubitemid 27148875)
12. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004 ; 351: 1741-1751
13. Schoeman JF, Springer P, van Rensburg AJ, et al. Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study. J Child Neurol. 2004 ; 19: 250-257 (Pubitemid 38660206)
14. Schoeman J, Mansvelt E, Springer P, et al. Coagulant and fibrinolytic status in tuberculous meningitis. Pediatr Infect Dis J. 2007 ; 26: 428-431 (Pubitemid 46789325)
15. Hankey GJ, Eikelboom JW. Antithrombotic drugs for patients with ischemic stroke and transient ischaemic attack to prevent recurrent major vascular events. Lancet Neurol. 2010 ; 9: 273-284
16. Moro MA, Cárdenas A, Hurtado O, et al. Role of nitric oxide after brain ischaemia. Cell Calcium. 2004 ; 36: 265-275 (Pubitemid 38992352)
17. Katsuyama K, Shichiri M, Kato H, et al. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells. Endocrinology. 1999 ; 140: 2183-2190 (Pubitemid 30636458)
18. Bousser MG. Antithrombotic agents in the prevention of ischemic stroke. Cerebrovasc Dis. 2009 ; 27: 12-19
19. Yasuda O, Takemura Y, Kawamoto H, Rakugi H. Aspirin: recent developments. Cell Mol Life Sci. 2008 ; 65: 354-358
20. O'Mahony D, Kendall MJ. Nitric oxide in acute ischaemic stroke: a target for neuroprotection. J Neurol Neurosurg Psychiatry. 1999 ; 67: 1-3 (Pubitemid 29278316)
21. Wang T, Fu FH, Han B, et al. Aspirin attenuates cerebral ischemic injury in diabetic rats. Exp Clin Endocrinol Diabetes. 2009 ; 117: 181-185
22. Iadecola C, Zhang F, Casey R, et al. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci. 1997 ; 17: 9157-9164 (Pubitemid 27498443)
23. Schrör K. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Semin Thromb Hemost. 1997 ; 23: 349-356 (Pubitemid 27360075)
24. Ikonomidis I, Andreotti F, Economou E, et al. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation. 1999 ; 100: 793-798 (Pubitemid 29398875)
25. Humphries MJ, Teoh R, Lau J, Gabriel M. Factors of prognostic significance in Chinese children with tuberculous meningitis. Tubercle. 1990 ; 71: 161-168 (Pubitemid 20287003)